Washington, DC - Smithfield Packaged Meats Corp., doing business as Stefano Foods., a Charlotte, N.C. establishment, is recalling approximately 24,048 pounds of pepperoni five cheese calzones that may be contaminated with extraneous materials, specifically pieces of hard, sharp, clear plastic, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced.

Washington, DC - On Thursday, October 18, 2018, the National Institute of Standards and Technology (NIST), in coordination with the Department of Defense (DoD) and the National Archives and Records Administration (NARA), is hosting an informational workshop providing an overview of Controlled Unclassified Information (CUI), the Defense Acquisition Regulations System (DFARS) Safeguarding Covered Defense Information and Cyber Incident Reporting Clause, and NIST Special Publications 800-171 and 800-171A.

Sacramento, California - On behalf of all Californians, Governor Edmund G. Brown Jr. and First Lady Anne Gust Brown honor Army Staff Sgt. David Rosenkrantz, a U.S. serviceman missing from World War II.

Washington, DC - At the FDA, we’re continuing to look at ways we can foster greater access to the medicines that help keep people healthy. We are considering all options for positively impacting both access and the cost of health care, and today we are announcing a new effort to establish innovative approaches to increase access to a broader selection of nonprescription drug products for consumers, empowering them to self-treat common conditions and potentially some chronic conditions.

Washington, DC - The Federal Trade Commission responded to the U.S. Department of Health and Human Services’ request for comment to its publication, Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. The publication seeks to “increase competition and end the gaming of regulatory processes that may keep drug prices artificially inflated or hinder generic, branded, or biosimilar competition.”

Washington, DC - The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication today in the Federal Register establishes that DEA will take into consideration the extent that a drug is diverted for abuse when it sets its annual opioid production limits.